Online Trial Tracker - Larvol Sigma

masupirdine (SUVN-502) / Suven Life Sci

Welcome, Profile Billing Logout

1 Trials

All TrialsPhase N/A

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

masupirdine (SUVN-502) / Suven Life Sci

SUVN-502, NCT03564964: Expanded Access to Provide for the Treatment of Subjects With Alzheimer's Disease

No Longer Available

N/A

SUVN-502

Suven Life Sciences Limited

Alzheimer Disease, Dementia, Cognition Disorders

Download Options



	Diseases Companies Products Productz Mechanisms of Action Sites